.Regeneron is actually back with lasting follow-up for its LAG-3 inhibitor and PD-1 inhibitor combo ...
.AstraZeneca has shared a very early check out the efficiency of its own internal antibody-drug conj...
.After announcing a period 3 launch based upon good midstage end results, iTeos as well as GSK are e...
.The FDA should be actually much more open and also collective to unleash a rise in commendations of...
.It's an uncommonly occupied Friday for biotech IPOs, with Zenas BioPharma, MBX and Bicara Therapies...
.Atea Pharmaceuticals' antiviral has actually neglected an additional COVID-19 test, yet the biotech...
.Neurocrine Biosciences' schizophrenia plan pivot has actually fallen short. The biotech was incapab...
.Sanofi has made a late entry to the radioligand party, paying out 100 million euros ($ 110 thousand...
.After F2G's first effort to obtain a brand-new class of antifungal to market was wrecked by the FDA...
.Moderna has sworn to cut R&D investing through $1.1 billion by 2027. The selection to retract th...